Liver Cancer Drugs Market Revenue 2025 to 2034
Liver Cancer Drugs Market Revenue 2025 to 2034
The liver cancer drugs market is expected to grow from USD 3.48 billion in 2025 to USD 11.5 billion by 2034, with a CAGR of 14.2% throughout the forecast period from 2025 to 2034.
Report ID: 10127
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 3.05 Bn
Forecast Year,
USD USD 11.5 Bn
CAGR, 2025 -
14.2%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Liver Cancer Drugs Market Size Analysis
Liver Cancer Drugs Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Targeted Therapy | 1677.50 | 1922.67 | 2203.65 | 2525.65 | 2894.67 | 3317.56 | 3802.18 | 4357.54 | 4993.96 | 5723.26 | 6558.97 |
| Immunotherapy | 915.00 | 1048.41 | 1201.27 | 1376.39 | 1577.02 | 1806.88 | 2070.23 | 2371.92 | 2717.56 | 3113.53 | 3567.16 |
| Chemotherapy | 457.50 | 512.02 | 572.79 | 640.50 | 715.89 | 799.77 | 893.04 | 996.67 | 1111.73 | 1239.37 | 1380.84 |
Liver Cancer Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 1830.00 | 2093.34 | 2394.58 | 2739.15 | 3133.29 | 3584.15 | 4099.86 | 4689.77 | 5364.54 | 6136.38 | 7019.25 |
| Retail Pharmacy | 762.50 | 869.03 | 990.45 | 1128.82 | 1286.52 | 1466.24 | 1671.07 | 1904.49 | 2170.52 | 2473.70 | 2819.21 |
| Online Pharmacy | 457.50 | 520.72 | 592.68 | 674.57 | 767.76 | 873.82 | 994.52 | 1131.88 | 1288.19 | 1466.08 | 1668.51 |
Liver Cancer Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1159.00 | 1325.32 | 1515.50 | 1732.98 | 1981.65 | 2266.01 | 2591.17 | 2962.97 | 3388.13 | 3874.28 | 4430.18 |
| Europe | 823.50 | 942.18 | 1077.96 | 1233.30 | 1411.02 | 1614.35 | 1846.97 | 2113.10 | 2417.57 | 2765.90 | 3164.42 |
| Asia-Pacific | 701.50 | 802.85 | 918.85 | 1051.60 | 1203.52 | 1377.38 | 1576.35 | 1804.05 | 2064.64 | 2362.86 | 2704.14 |
| Latin America | 213.50 | 242.08 | 274.46 | 311.16 | 352.75 | 399.88 | 453.28 | 513.79 | 582.33 | 659.99 | 747.95 |
| Middle East & Africa | 152.50 | 170.67 | 190.93 | 213.50 | 238.63 | 266.59 | 297.68 | 332.22 | 370.58 | 413.12 | 460.28 |
Liver Cancer Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
